The effect of different case definitions of current smoking on the discovery of smoking - Related blood gene expression signatures in chronic obstructive pulmonary disease

Nicotine and Tobacco Research

Volumn 18, Issue 9, 2016, Pages 1903-1909

  Obeidat, Ma'en ^a   Ding, Xiaoting ^a   Fishbane, Nick ^a   Hollander, Zsuzsanna ^a,b   Ng, Raymond T ^b,c   McManus, Bruce ^a,b   Tebbutt, Scott J ^a,b   Miller, Bruce E ^d   Rennard, Stephen ^e   Paré, Peter D ^a,c   Sin, Don D ^a,c  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b Prevention of Organ Failure Centre of Excellence   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d GLAXOSMITHKLINE   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; ALPHA LEVO FUCOSIDASE; CARRIER PROTEIN; FUCA1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GPR15 PROTEIN, HUMAN; LRRN3 PROTEIN, HUMAN; MEMBRANE PROTEIN; PID1 PROTEIN, HUMAN; RECEPTOR; TRANSCRIPTOME; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FUCA1 GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GPR15 GENE; HUMAN; HYPOXIA; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; LRRN3 GENE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTICENTER STUDY; PHENOTYPE; PID1 GENE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; SELF REPORT; SMOKING; ADVERSE EFFECTS; GENETICS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

ADULT; AGED; ALPHA-L-FUCOSIDASE; CARBON MONOXIDE; CARRIER PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RISK FACTORS; SELF REPORT; SMOKING; TRANSCRIPTOME;

EID: 84988874492     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw129     Document Type: Article

References (53)

1. WHO. Tobacco Fact Sheet. Geneva, Switzerland: World Health Organization; 2015.
2. Peto RLA, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2020. 2015. www.ctsu.ox.ac.uk/~tobacco. Accessed January 15, 2015.
3. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. NEJM. 2014;370(1):60-68.
4. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9(9):655-664.
5. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ. 1976;2(6051):1525-1536.
6. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128.
7. (CIHI)" CIfHI. A Snapshot of Health Care in Canada as Demonstrated by Top 10 Lists, 2011. Ottawa, Canada: CIHI; 2011.
8. Stelmach R, Fernandes FLA, Carvalho-Pinto RM, et al. Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth? J Brasileiro de Pneum. 2015;41(2):124-132.
9. Fendrich M, Mackesy-Amiti ME, Johnson TP, Hubbell A, Wislar JS. Tobacco-reporting validity in an epidemiological drug-use survey. Add Beh. 2005;30(1):175-181.
10. Sato S, Nishimura K, Koyama H, et al. Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest. 2003;124(5):1749-1754.
11. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. BMJ. 1980;281(6238):484-485.
12. Edmiston JS, Archer KJ, Scian MJ, Joyce AR, Zedler BK, Murrelle EL. Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers. Biomarkers. 2010;15(8):715-730.
13. Poliska S, Csanky E, Szanto A, et al. Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function. Respiration. 2011;81(6):499-510.
14. Bahr TM, Hughes GJ, Armstrong M, et al. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cel Mol Biol. 2013;49(2):316-323.
15. Bhattacharya S, Tyagi S, Srisuma S, et al. Peripheral blood gene expression profiles in COPD subjects. J Clin Bio. 2011;1(1):12.
16. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). ERJ. 2008;31(4):869-873.
17. Obeidat M, Fishbane N, Nie Y, et al. The Effect of Statins on Blood Gene Expression in COPD. PLoS One. 2015;10(10):e0140022.
18. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363-2367.
19. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
20. Hochreiter S, Clevert D-A, Obermayer K. A new summarization method for affymetrix probe level data. Bioinformatics. 2006;22(8):943-949.
21. YOUDEN WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-35.
22. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Gen Mol Bio. 2004;3(1):1-25.
23. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multi Beh Res. 2011;46(3):399-424.
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Series B (Methodological). 1995;57(1):289-300.
25. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nuc Aci Res. 2013;41(W1):W77-W83.
26. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23(2):257-258.
27. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.
28. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Gen Bio. 2004;5(10):R80.
29. Charlesworth J, Curran J, Johnson M, et al. Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes. BMC Med Gen. 2010;3(1):29.
30. Wan ES, Qiu W, Baccarelli A, et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Gen. 2012;21(13):3073-3082.
31. Beineke P, Fitch K, Tao H, et al. A whole blood gene expression-based signature for smoking status. BMC Med Gen. 2012;5(1):58.
32. Bosse Y, Postma DS, Sin DD, et al. Molecular Signature of Smoking in Human Lung Tissues. Can Res. 2012.
33. Guida F, Sandanger TM, Castagné R, et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum Mol Gen. 2015;24(8):2349-2359.
34. Kim WJ, Lim MN, Hong Y, et al. Association of lung function genes with chronic obstructive pulmonary disease. Lung. 2014;192(4):473-480.
35. Haines BP, Gupta R, Jones CM, Summerbell D, Rigby PW. The NLRR gene family and mouse development: modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Dev Biol. 2005;281(2):145-159.
36. Chen Y, Aulia S, Li L, Tang BL. AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res Rev. 2006;51(2):265-274.
37. Sousa I, Clark T, Holt R, et al. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. Mol Auti. 2010;1(1):7.
38. Erdreich-Epstein A, Robison N, Ren X, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin Cancer Res. 2014;20(4):827-836.
39. Sabeera B, Craig M, Jackie A, et al. Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity. Mol Endo. 2013;27(9):1518-1535.
40. Leray G, Deugnier Y, Jouanolle AM, et al. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma. Hepatology. 1989;9(2):249-252.
41. Wang K, Guo W, Li N, et al. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, longterm study. Brit J Can. 2014;110(7):1811-1819.
42. Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol. 2005;79(3):1686-1700.
43. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg. 1991;126(9):1131-1134.
44. Morecraft R, Blair WF, Brown TD, Gable RH. Acute effects of smoking on digital artery blood flow in humans. J Hand Surg Am. 1994;19(1):1-7.
45. Sagone AL Jr, Lawrence T, Balcerzak SP. Effect of smoking on tissue oxygen supply. Blood. 1973;41(6):845-851.
46. Grassi D, Desideri G, Ferri L, Aggio A, Tiberti S, Ferri C. Oxidative stress and endothelial dysfunction: say NO to cigarette smoking! Curr Pharm Des. 2010;16(23):2539-2550.
47. van Zyl-Smit RN, Binder A, Meldau R, et al. Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages. Thorax. 2014;69(4):363-370.
48. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298(6676):784-788.
49. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Euro J Endo. 2005;152(4):491-499.
50. Bloom AJ, Hartz SM, Baker TB, et al. Beyond cigarettes per day. A genomewide association study of the biomarker carbon monoxide. Ann Am Thorac Soc. 2014;11(7):1003-1010.
51. Sandberg A, Sköld CM, Grunewald J, Eklund A, Wheelock ÅM. Assessing recent smoking status by measuring exhaled carbon monoxide levels. PLoS One. 2011;6(12):e28864.
52. Ryter SW, Sethi JM. Exhaled carbon monoxide as a biomarker of inflammatory lung disease. J Breath Res. 2007;1(2):026004.
53. Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, Barnes PJ. Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax. 1998;53(10):867-870.